IRD
Opus Genetics, Inc.
OpenVolumeMkt capP/EEPSDiv yield
Day – 52-wk –
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
Last reportshaded = implied▲▼ = realized× = |realized| ÷ implied
Opus Genetics, Inc.
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
Last reportshaded = implied▲▼ = realized× = |realized| ÷ implied
Opus Genetics, Inc.
3.64
Fund move
Fund move
No thesis.
Linked news
News| Rank | Manager | Value | % 13F | ||
|---|---|---|---|---|---|
| 1 | Caligan PartnersCaligan Partners | $25.0M | 10.56% | +0.03% | |
| 2 | Adage Capital Partners GPAdage Capital Partners GP | $24.8M | 10.48% | 0.00% | |
| 3 | BIOS Capital ManagementBIOS | $15.1M | 6.40% | 0.00% | |
| 4 | BlackRockBlackRockindex-like | $12.8M | 5.42% | +2009.44% | |
| 5 | Balyasny Asset ManagementBalyasny | $12.7M | 5.37% | +13.61% | |
| 6 | Nantahala Capital ManagementNantahala | $12.6M | 5.32% | +82.08% | |
| 7 | Vanguard Capital ManagementVanguardindex-like | $12.2M | 5.14% | +20.76% | |
| 8 | Boxer Capital ManagementBoxer | $11.6M | 4.89% | +25.11% | |
| 9 | Trails Edge Capital PartnersTrails Edge Capital Partners | $11.3M | 4.77% | +448.73% | |
| 10 | Millennium ManagementMillennium | $9.5M | 4.00% | −12.48% | |
| 11 | Great Point PartnersGreat Point Partners | $8.1M | 3.42% | +507.44% | |
| 12 | Marshall WaceMarshall Wace | $8.0M | 3.38% | −15.90% | |
| 13 | ADAR1 Capital ManagementADAR1 | $7.3M | 3.10% | −3.53% | |
| 14 | Goldman Sachs GroupGoldman Sachs | $6.3M | 2.65% | +367.32% | |
| 15 | Woodline PartnersWoodline Partners | $5.9M | 2.49% | +5.96% | |
| 16 | Geode Capital ManagementGeodeindex-like | $5.6M | 2.38% | +154.06% | |
| 17 | Boothbay Fund ManagementBoothbay Fund | $4.9M | 2.07% | +0.03% | |
| 18 | Opaleye ManagementOpaleye | $4.6M | 1.96% | +0.45% | |
| 19 | SummitTX CapitalSummitTX Capital | $4.1M | 1.75% | new | |
| 20 | State StreetState Streetindex-like | $3.2M | 1.37% | +295.16% | |
| 21 | BleichroederBleichroeder | $3.0M | 1.28% | 0.00% | |
| 22 | UBS GroupUBS | $2.8M | 1.19% | +165.44% | |
| 23 | Citadel AdvisorsCitadel | $2.7M | 1.16% | +450.59% | |
| 24 | Morgan StanleyMorgan Stanley | $1.9M | 0.81% | +1076.31% | |
| 25 | Northern TrustNorthern Trustindex-like | $1.8M | 0.77% | +368.31% |
103 managers report $236.5M of Opus Genetics on form 13F for the quarter ended Jun 30 '26. 17 of them hold 80% of it; Caligan Partners is largest at 10.56%.
No implied move.
No implied move.
Expected move
No implied move.